KAITLYN BENNORTH: Open Payments
NPI 1730790346 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 100 payments from 15 companies in 2025. Trend: 2023 $1,997 · 2024 $2,017 · 2025 $1,793
Food & beverage: $1,793
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $455 |
| Regeneron Healthcare Solutions, Inc. | 10 | $277 |
| UCB, Inc. | 10 | $249 |
| ABBVIE INC. | 13 | $164 |
| Lilly USA, LLC | 8 | $160 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Incyte Corporation | 3 | $71 |
| Amgen Inc. | 3 | $55 |
| Organon LLC | 2 | $52 |
| Galderma Laboratories, L.P. | 3 | $44 |
Products named: TREMFYA, Bimzelx, DUPIXENT, TALTZ, LIBTAYO, RINVOQ, OPZELURA, COSENTYX.
Industry payments across TN — which companies pay providers there.
